Multilevel competing risks in the evaluation of nosocomial infections: time to move on from proportional hazards and even from hazards altogether
- 1.1k Downloads
A competing risk is an event (for example, death in the ICU) that hinders the occurrence of an event of interest (for example, nosocomial infection in the ICU) and it is a common issue in many critical care studies. Not accounting for a competing event may affect how results related to a primary event of interest are interpreted. In the previous issue of Critical Care, Wolkewitz and colleagues extended traditional models for competing risks to include random effects as a means to quantify heterogeneity among ICUs. Reported results from their analyses based on cause-specific hazards and on sub-hazards of the cumulative incidence function were indicative of lack of proportionality of these hazards over time. Here, we argue that proportionality of hazards can be problematic in competing-risk problems and analyses must consider time by covariate interactions as a default. Moreover, since hazards in competing risks make it difficult to disentangle the effects of frequency and timing of the competing events, their interpretation can be murky. Use of mixtures of flexible and succinct parametric time-to-event models for competing risks permits disentanglement of the frequency and timing at the price of requiring stronger data and a higher number of parameters. We used data from a clinical trial on fluid management strategies for patients with acute respiratory distress syndrome to support our recommendations.
KeywordsNosocomial Infection Cumulative Incidence Function Hazard Type Infection Control Strategy Unassisted Breathing
In the previous issue of Critical Care, Wolkewitz and colleagues  analyzed data from a multi-center cohort study of 159 ICUs and 109,202 admissions to better understand how both patient-level and ICU-level characteristics affect nosocomial infections (NIs). NIs are a leading cause of death in the ICU despite being largely preventable . Reductions of up to 70% have been achieved via infection control strategies for specific NIs , but this has not been universal across settings. Thus, it is important to define both high-risk patients and high-risk settings and identify interventions that prevent NIs, for which data analysis methods to determine risk factors for specific events are pertinent. Wolkewitz and colleagues  acknowledge the difficulty of the problem caused by heterogeneity across ICUs and the importance of competing risks when analyzing risk factors for NIs and present a statistical approach to handle both of these complexities.
Heterogeneity across intensive care units
In recent years, increasing attention has been given to the role of ICU organization and processes of care on patient-centered outcomes [4, 5, 6, 7, 8, 9]. Some of these previous investigations have also recognized substantial heterogeneity in ICU organization [4, 9] that can contribute to variations in rates of mortality of critically ill patients across hospitals and may help explain why some interventions achieve improvements only in specific settings. By using a multilevel approach to analyze patient-level and ICU-level characteristics, Wolkewitz and colleagues thereby avoid loss of valuable information that may help explain differences in clinical outcomes.
Competing risks in critical care
Competing risks are important in the ICU because a large proportion of patients may be discharged or die before developing the event of interest (for example, NIs). To account for competing risks, Wolkewitz and colleagues  extended methods to compare cause-specific hazards (CSHs) and sub-hazards (SUBHs) of the cumulative incidence functions between study groups  by incorporating random effects to quantify heterogeneity. However, despite wide recognition that proportionality of hazards does not occur in most situations, their results are presented under such an assumption.
Time to move on from proportionality of hazards
Proportionality of hazards has additional hurdles in competing risks . In the case of two competing risks, proportionality cannot hold simultaneously for all CSHs and SUBHs . Specifically, at most two of the four (two events and two types of hazards) can be proportional but without restriction of which two . Even in the case in which two of the four hazards are proportional, there is strong tethering between the hazard ratios . In particular, when the CSHs and SUBHs for a given event type simultaneously fulfill proportionality, the two hazard ratios must be equal and this fact holds regardless of the number of competing risks. A consequence of this result is that analyses reporting CSH and SUBH ratios with different values divulge a lack of proportionality in at least one of the hazard types, as is the case in the analysis by Wolkewitz and colleagues  for number of beds, Acute Physiology and Chronic Health Evaluation II score, days in hospital, type of diagnosis and trauma as presented in their Table 2. Fine and Gray  anticipated that a lack of proportionality would be common in competing-risk problems. While it is possible to test for a lack of proportionality, power is often limited in most situations (for example, short follow-up time or heavy censoring). Thus, default analyses should include covariate and time interactions which can be easily calculated and depicted .
Even time to move on from hazards altogether
Hazards as a metric of disease occurrence along with semi-parametric methods have provided a means to understanding many diseases. However, hazards have limitations  that become compounded in competing-risk problems: CSHs and SUBHs are decoupled; CSHs lack specificity as they are strongly influenced by the competing event; SUBHs are specific but they are intrinsically tethered because their cumulative incidences must add up to one; both CSHs and SUBHs combine frequency and timing of events, making it difficult to identify exposures that modify only the timing of an event but not the frequency.
AM was supported by the National Institutes of National Diabetes and Digestive and Kidney Diseases (UO1-DK-66116). WC was supported by a K99/R00 Pathway to Independence Award (R00HL096955) from the National Heart, Lung and Blood Institute, National Institutes of Health. The authors thank ARDS Network Investigators for use of the Fluid and Catheter Treatment Trial data.
- 4.Checkley W, Martin GS, Brown SM, Chang SY, Dabbagh O, Fremont RD, Girard TD, Rice TW, Howell MD, Johnson SB, O’Brien J, Park PK, Pastores SM, Patil NT, Pietropaoli AP, Putman M, Rotello L, Siner J, Sajid S, Murphy DJ, Sevransky JE, United States Critical Illness and Injury Trials Group Critical Illness Outcomes Study Investigators: Structure, process, and annual ICU mortality across 69 centers: United States critical illness and injury trials group critical illness outcomes study. Crit Care Med 2014, 42: 344-356. 10.1097/CCM.0b013e3182a275d7PubMedPubMedCentralCrossRefGoogle Scholar
- 8.Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, EPIC II Group of Investigators: International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009, 302: 2323-2329. 10.1001/jama.2009.1754PubMedCrossRefGoogle Scholar
- 9.Vincent JL, Marshall JC, Namendys-Silva SA, François B, Martin-Loeches I, Lipman J, Reinhart K, Antonelli M, Pickkers P, Njimi H, Jimenez E, Sakr Y, On behalf of the ICON investigators: Assessment of the worldwide burden of critical illness: the intensive care over Nations (ICON) audit. Lancet Respir Med 2014, 2: 38-386.CrossRefGoogle Scholar
- 17.Checkley W, Brower RG, Muñoz A, NIH Acute Respiratory Distress Syndrome Network Investigators: Inference for mutually exclusive competing events through a mixture of generalized gamma distributions. Epidemiology 2010, 21: 557-565. 10.1097/EDE.0b013e3181e090edPubMedPubMedCentralCrossRefGoogle Scholar
This article is published under license to BioMed Central Ltd. The licensee has exclusive rights to distribute this article, in any medium, for 6 months following its publication. After this time, the article is available under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.